Using benchmarks based on historical survival rates for screening new therapies for stage IV melanoma patients.
Gimotty
Phyllis A
PA
Guerry
DuPont
D
Flaherty
Keith
K
D019985:Benchmarking; D017326:Clinical Trials, Phase III as Topic; D006801:Humans; D008545:Melanoma / Q000401:mortality* / Q000473:pathology / Q000556:secondary / Q000628:therapy*; D009367:Neoplasm Staging; D011379:Prognosis; D012107:Research Design / Q000592:standards; D018401:Sample Size; D012878:Skin Neoplasms / Q000401:mortality* / Q000473:pathology / Q000628:therapy*